Weight loss in obese girls with polycystic ovarian syndrome is associated with a decrease in Anti-Muellerian Hormone concentrations (Q47218988)

12 January 2018

title

Weight loss in obese girls with polycystic ovarian syndrome is associated with a decrease in Anti-Muellerian Hormone concentrations (English)

1 reference

12 January 2018

0 references

1

Thomas Reinehr

1 reference

12 January 2018

Alexandra Kulle

2

1 reference

12 January 2018

Juliane Rothermel

3

1 reference

12 January 2018

Caroline Knop

4

1 reference

12 January 2018

Nina Lass

5

1 reference

12 January 2018

Christina Bosse

6

1 reference

12 January 2018

Paul-Martin Holterhus

7

1 reference

12 January 2018

publication date

22 April 2017

1 reference

12 January 2018

published in

Clinical Endocrinology

1 reference

12 January 2018

volume

87

1 reference

12 January 2018

page(s)

185-193

1 reference

12 January 2018

issue

2

1 reference

12 January 2018

Polycystic Ovary Syndrome

cites work

1 reference

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

21 January 2018

1 reference

Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline

21 January 2018

1 reference

The Diagnosis of Polycystic Ovary Syndrome during Adolescence.

21 January 2018

1 reference

Antimüllerian hormone levels are independently related to ovarian hyperandrogenism and polycystic ovaries

21 January 2018

1 reference

Anti-Müllerian Hormone in Obese Adolescent Girls With Polycystic Ovary Syndrome.

21 January 2018

1 reference

Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest.

21 January 2018

1 reference

Serum antimüllerian hormone in response to dietary management and/or physical exercise in overweight/obese women with polycystic ovary syndrome: secondary analysis of a randomized controlled trial

21 January 2018

1 reference

Anti-müllerian hormone: a valuable addition to the toolbox of the pediatric endocrinologist

21 January 2018

1 reference

The effect of weight loss on anti-Müllerian hormone levels in overweight and obese women with polycystic ovary syndrome and reproductive impairment

21 January 2018

1 reference

Diet, physical exercise and Orlistat administration increase serum anti-Müllerian hormone (AMH) levels in women with polycystic ovary syndrome (PCOS).

21 January 2018

1 reference

Which Amount of BMI-SDS Reduction Is Necessary to Improve Cardiovascular Risk Factors in Overweight Children?

21 January 2018

1 reference

Menstruation in girls and adolescents: using the menstrual cycle as a vital sign

21 January 2018

1 reference

A novel ultrapressure liquid chromatography tandem mass spectrometry method for the simultaneous determination of androstenedione, testosterone, and dihydrotestosterone in pediatric blood samples: age- and sex-specific reference data

21 January 2018

1 reference

Establishing a standard definition for child overweight and obesity worldwide: international survey

21 January 2018

1 reference

Serum anti-Müllerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3.

21 January 2018

1 reference

Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome

21 January 2018

1 reference

Anti-Mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels

21 January 2018

1 reference

Serum anti-Müllerian hormone (AMH) levels are differentially modulated by both serum gonadotropins and not only by serum follicle stimulating hormone (FSH) levels

21 January 2018

1 reference

Body mass index patterns over 5 y in obese children motivated to participate in a 1-y lifestyle intervention: age as a predictor of long-term success.

21 January 2018

1 reference

Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome

21 January 2018

1 reference

Discordances between follicle stimulating hormone (FSH) and anti-Müllerian hormone (AMH) in female infertility

21 January 2018

1 reference

Relationship between anti-Müllerian hormone (AMH) and insulin levels during different tanner stages in daughters of women with polycystic ovary syndrome.

21 January 2018

1 reference

Circulating Anti-Müllerian Hormone Levels in Daughters of Women with and without Polycystic Ovary Syndrome

21 January 2018

1 reference

Mullerian-inhibiting substance in women with polycystic ovary syndrome: relationship with hormonal and metabolic characteristics

21 January 2018

1 reference

Anti-müllerian hormone and anti-müllerian hormone type II receptor messenger ribonucleic acid expression in rat ovaries during postnatal development, the estrous cycle, and gonadotropin-induced follicle growth.

21 January 2018

1 reference

Anti-Müllerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age.

21 January 2018

1 reference

The role of AMH in the pathophysiology of polycystic ovarian syndrome.

21 January 2018

1 reference

Anti-Mullerian hormone in the diagnosis of polycystic ovary syndrome: can morphologic description be replaced?

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/CEN.13358

1 reference

12 January 2018

PubMed ID

28432801

1 reference

12 January 2018